Sun Pharmaceutical Industries, India's third-largest generic drugmaker by sales, said on Wednesday it had acquired US-based Pharmalucence Inc, which has sterile injectable capacity and research capabilities.
Financial details of the deal were not disclosed.
Copyright: Thomson Reuters 2014
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
